STATEMENT FROM OUR EDITOR-IN-CHIEF

It is with great enthusiasm and a deep sense of responsibility that I have assumed the role of Editor-in-Chief of Aging-US, effective January 1, 2025. Throughout my career at the intersection of aging research, cellular senescence, and translational science, I have witnessed the transformative potential that deeper insights into the biology of aging can have on healthspan and overall quality of life. This is why I am honored to guide Aging-US into its next chapter.

My research actively focuses on the molecular mechanisms underlying aging, with particular emphasis on cellular senescence. I am especially interested in the fundamental molecular pathways that govern the induction and maintenance of senescence, as well as their functional roles in tissue remodeling, inflammation, and age-related diseases. In parallel, I lead interdisciplinary teams and foster collaborations aimed at translating these insights into therapeutic strategies, while also mentoring the next generation of scientists.

As Editor-in-Chief, I will draw upon this ongoing experience to ensure that Aging-US remains a premier platform for high-impact, innovative research. I am committed to advancing the journal’s mission by promoting rigorous science and encouraging interdisciplinary dialogue that bridges basic biology with clinical relevance. In a field as complex and multifaceted as aging, collaboration across disciplines is not just valuable—it is essential.

I look forward to working closely with our outstanding editorial board, contributors, and readers to shape the future of aging research. Together, we will continue to expand the frontiers of knowledge and work toward actionable solutions that improve lives around the globe.

I am excited to embark on this journey with all of you.

For more information about Marco Demaria, PhD, please visit www.demarialab.com and follow him on X (Twitter) @marc_dema or on Bluesky @marcdema.bsky.social.